J. Derek Lewis & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
J. Derek Lewis & Associates's LLY Position: Q2 2026 in Review
J. Derek Lewis & Associates increased its Eli Lilly (LLY) stake by 1.7% in Q2 2026, buying an estimated $19.4K and bringing the position to 1,137 shares worth $1.36M. The position accounts for 0.26% of the portfolio, ranked #49.
J. Derek Lewis & Associates first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- J. Derek Lewis & Associates held 1,137 shares of Eli Lilly worth $1.36M as of Q2 2026.
- J. Derek Lewis & Associates bought 19 Eli Lilly shares in Q2 2026, an estimated $19.4K.
- Eli Lilly made up 0.26% of J. Derek Lewis & Associates's portfolio in Q2 2026, its #49 holding.
- J. Derek Lewis & Associates first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on J. Derek Lewis & Associates's 13F filing for Q2 2026, filed 31 Jul 2026.